PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Cancer Research and Treatment10.4143/crt.2005.37.6.3492005376349A Multi-Center, Phase II Clinical Trial of Padexolâ„¢ (Paclitaxel) and Cisplatin for Patients Suffering with Advanced Gastric CancerMin Kyoung Kim, Kyung Hee Lee, Myung Soo Hyun, Young Rok Do, Hong Suk Song, Won Sik Lee, Keon Uk Park, Jin Ho Baek, Jong Gwang Kimhttp://www.e-crt.org/upload/pdf/crt-37-349.pdf, http://www.e-crt.org/upload/pdf/crt-37-349.pdf
Oncology10.1159/0003287462011801-276-83A Phase II Multi-Center Study of Triple Therapy with Paclitaxel, S-1 and Cisplatin in Patients with Advanced Gastric CancerH. Iwase, M. Shimada, T. Tsuzuki, K. Ina, M. Sugihara, J. Haruta, M. Shinoda, T. Kumada, H. Gotohttps://www.karger.com/Article/Pdf/328746, https://www.karger.com/Article/Pdf/328746, https://www.karger.com/Article/Pdf/328746
British Journal of Cancer10.1038/bjc.2012.2222012107131-36Phase II multi-institutional prospective randomised trial comparing S-1+paclitaxel with S-1+cisplatin in patients with unresectable and/or recurrent advanced gastric cancerE Mochiki, , K Ogata, T Ohno, Y Toyomasu, N Haga, Y Fukai, R Aihara, H Ando, N Uchida, T Asao, H Kuwanohttp://www.nature.com/articles/bjc2012222.pdf, http://www.nature.com/articles/bjc2012222, http://www.nature.com/articles/bjc2012222.pdf
Gastric Cancer10.1007/s10120-011-0043-32011144332-338Phase II study of weekly paclitaxel, cisplatin, and 5-fluorouracil for advanced gastric cancerTakuo Hara, Kazuhiro Nishikawa, Mitsuaki Sakatoku, Koji Oba, Junichi Sakamoto, Kenji Omurahttp://link.springer.com/content/pdf/10.1007/s10120-011-0043-3.pdf, http://link.springer.com/article/10.1007/s10120-011-0043-3/fulltext.html, http://link.springer.com/content/pdf/10.1007/s10120-011-0043-3, http://link.springer.com/content/pdf/10.1007/s10120-011-0043-3.pdf
Lung Cancer10.1016/s0169-5002(03)92709-7200341S278-S27918 A multi-center, phase II clinical trial of genexol(paclitaxel) and cisplatin in patients with non-small cell lung cancerHoon-Kyo Kim, Se-Hoon Lee, Keunchil Park, Cheolwon Suh, Jun-Suk Kim, Young-Hyuck Im, Sang-We Kim, Dae-Seog Heo, Yung-Jue Bang, Noe Kyeong Kimhttps://api.elsevier.com/content/article/PII:S0169500203927097?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0169500203927097?httpAccept=text/plain
Gastric Cancer10.1007/s10120-002-0209-020025S123-26Docetaxel and cisplatin in patients with advanced gastric cancer: results of Japanese phase I/II studySoh Saitoh, Yuh Sakatahttp://link.springer.com/content/pdf/10.1007/s10120-002-0209-0.pdf, http://link.springer.com/article/10.1007/s10120-002-0209-0/fulltext.html, http://link.springer.com/content/pdf/10.1007/s10120-002-0209-0
Clinical Lung Cancer10.1016/s1525-7304(11)70577-019991294-95Randomized Phase III Trial Comparing Cisplatin/Gemcitabine/Vinorelbine to Cisplatin/Gemcitabine or Cisplatin/Vinorelbine in Patients with Advanced NSCLChttps://api.elsevier.com/content/article/PII:S1525730411705770?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1525730411705770?httpAccept=text/plain
British Journal of Cancer10.1038/sj.bjc.66042312008984720-727A phase II randomised clinical trial comparing cisplatin, paclitaxel and ifosfamide with cisplatin, paclitaxel and epirubicin in newly diagnosed advanced epithelial ovarian cancer: long-term survival analysisR Fruscio, N Colombo, A A Lissoni, A Garbi, R Fossati, N Ieda', V Torri, C Mangionihttp://www.nature.com/articles/6604231.pdf, http://www.nature.com/articles/6604231, http://www.nature.com/articles/6604231.pdf
Cancer Research and Treatment10.4143/crt.2008.40.3.1062008403106A Phase II Trial of Paclitaxel, 5-fluorouracil (5-FU) and Cisplatin in Patients with Metastatic or Recurrent Gastric CancerGun Hi Kang, Gwang Sil Kim, Hyo Rak Lee, Young Jin Yuh, Sung Rok Kimhttp://www.e-crt.org/upload/pdf/crt-40-106.pdf, http://www.e-crt.org/upload/pdf/crt-40-106.pdf
Annals of Oncology10.1016/s0923-7534(20)31967-0201223xi19Phase II Trial of Endostar Combined with Epirubicin, Cisplatin and 5-Fluorouracil in Patients with Advanced and Metastatic Gastric CancerX. Zhuhttps://api.elsevier.com/content/article/PII:S0923753420319670?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0923753420319670?httpAccept=text/plain